Literature DB >> 23421202

Progress of research in gastric cancer.

Zeeshan Ali1, Yan Deng, Chao Ma.   

Abstract

Gastric cancer (GC) has continued to be a threat to human life. Diagnosis of GC at advanced stage is considered as a major reason for lower overall five-year survival rate in developing countries. A complex set of molecular irregularities occurs at cellular level during early stage of GC and its further progression will disturb normal cell functioning. These abnormalities include genetic and epigenetic modifications leading to differential expression of many genes in normal and affected cells. Many efforts are made to spot these molecular aberrations to understand the underlying mechanism which governs abnormal cell behavior. Current review summarizes recent works addressing GC etiology, epidemiology, pathology and therapy treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23421202     DOI: 10.1166/jnn.2012.6692

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  16 in total

1.  SUZ12 promotes gastric cancer cell proliferation and metastasis by regulating KLF2 and E-cadherin.

Authors:  Rui Xia; Fei-yan Jin; Kai Lu; Li Wan; Min Xie; Tong-peng Xu; Wei De; Zhao-xia Wang
Journal:  Tumour Biol       Date:  2015-02-12

2.  Clinical value of propranolol combined with oxaliplatin and tigio in concurrent chemoradiotherapy for locally advanced gastric cancer.

Authors:  Yong Chen; Yu Chen; Zhibang Wang; He Li; Yongqi Wang
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

3.  Enhanced serum methylated p16 DNAs is associated with the progression of gastric cancer.

Authors:  Yi-Chen Wu; Ping Lv; Jing Han; Jiang-Liu Yu; Xin Zhu; Lian-Lian Hong; Wang-Yu Zhu; Qi-Ming Yu; Xin-Bao Wang; Pei Li; Zhi-Qiang Ling
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

4.  Novel findings about management of gastric cancer: a summary from 10th IGCC.

Authors:  Danila Penon; Letizia Cito; Antonio Giordano
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

5.  Association of MTOR and AKT Gene Polymorphisms with Susceptibility and Survival of Gastric Cancer.

Authors:  Ying Piao; Ying Li; Qian Xu; Jing-wei Liu; Cheng-zhong Xing; Xiao-dong Xie; Yuan Yuan
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

6.  XRCC7 rs#7003908 Polymorphism and Helicobacter pylori Infection-Related Gastric Antrum Adenocarcinoma.

Authors:  Chao Wang; Xiao-Ying Huang; Jin-Guang Yao; Bing-Chen Huang; Cen-Han Huang; Pinhu Liao; Xi-Dai Long
Journal:  Int J Genomics       Date:  2013-11-11       Impact factor: 2.326

7.  Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.

Authors:  Min Xie; Feng-qi Nie; Ming Sun; Rui Xia; Yan-wen Liu; Peng Zhou; Wei De; Xiang-hua Liu
Journal:  J Transl Med       Date:  2015-08-04       Impact factor: 5.531

8.  Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2).

Authors:  Xiangsheng Li; Zhichao Zhang; Ming Yu; Liqi Li; Guangsheng Du; Weidong Xiao; Hua Yang
Journal:  Int J Mol Sci       Date:  2013-08-06       Impact factor: 5.923

9.  microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2.

Authors:  Bin Wei; Ying Song; Yonghong Zhang; Mingjun Hu
Journal:  Oncol Lett       Date:  2013-10-09       Impact factor: 2.967

10.  Transduction motif analysis of gastric cancer based on a human signaling network.

Authors:  G Liu; D Z Li; C S Jiang; W Wang
Journal:  Braz J Med Biol Res       Date:  2014-05       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.